Good morning, everyone. Another brand new day is on the way. Of course, this calls for a hearty cup of stimluation - our flavor today is Cinnamon Cream Swirl. Feel free to grab one yourself, or a bottle of water if you prefer, and join us as we peruse the news of the world. As always, we appreciate tips and hints and allegations. So send them our way. Meanwhile, have a great day and see you soon...
J&J May Do $10B Deals To Bolster Growth (Bloomberg News)
Synthetic Drugs Send Thousands To Emergency Rooms (Associated Press)
Merck's Dutch R&D Unit To Keep Some Jobs After All (Reuters)
The Valent Pharma CEO And His Acquisition Binge (Bloomberg News)
Where Are The ImClone Alumni? (Xconomy)
FDA Approves Restless Legs Syndrome Med (Reuters)
AstraZeneca Wins FDA Approval Of Thyroid Cancer Drug (Bloomberg News)
Japan Is Short On Some Drugs (Daily Yomiuiri)
Shire Sues Watson Over Adderall XR Generics (Pharma Times)
Novartis Sells Skin Drug To Meda For $420M (Reuters)
Some Doctors Ask Patients To Sign Pain Pill Contracts (MSNBC)
Glaxo Is Bidding For Turkey's Biofarma (Bloomberg News)
Tokyo Iressa Plaintiffs Appeal Court Ruling (Japan Today)
SuperGen And Astex Agree To Merger (San Francisco Business Times)
EDITOR'S NOTE: Please check back for updates headlines throughout the morning.
1 Comment
Ed, Good morning!
I never would have taken you for a cinnamon cream swirl coffee drinker...